PLUS THERAPEUTICS, INC. — Director's Dealing 2020

Jul 1, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2020-06-25

Reporting Person: van Es-Johansson An (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-25	Stock Option (Right to Buy)	$2.10	A	34000	Acquired	2030-06-25	Common Stock (34000)	Direct

Footnotes

F1: The options vest in equal 1/19th increments on the 9th of every month with the first 1/19th increment vesting on July 9, 2020 and the last 1/19th increment vesting on January 9, 2022.